Baker Mark Robert 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Mar 28, 2013
Insider Transaction Report
Form 4
Baker Mark Robert
General Counsel
Transactions
- Purchase
Common Stock
2013-03-27$5.31/sh+500$2,655→ 160,991 total - Purchase
Common Stock
2013-03-27$5.34/sh+50$267→ 161,041 total - Purchase
Common Stock
2013-03-27$5.36/sh+100$536→ 161,141 total
Footnotes (1)
- [F1]Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.